Thus far, the down-regulation of adiponectin and its receptors has been well described in chronic conditions associated with low-grade inflammation such as obesity and type II DM (Kadowaki et al., 2006; Kern et al., 2003). This evidence concerns the gene ADIPOQ and obesity disorder.